Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Assessment of Low-dose ASA Discontinuation Risk Associated With Concomitant PPI Use During the First Year of ASA Therapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01888575
Recruitment Status : Completed
First Posted : June 28, 2013
Last Update Posted : May 13, 2014
Sponsor:
Information provided by (Responsible Party):
AstraZeneca